Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Sodium Chloride Inhalation Solution, USP 0.9%, 3% & 7%

K-Number: K232523 · 2024-04-10

Decision Date2024-04-10
Product CodeCAF
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

Sodium Chloride Inhalation Solution, USP 0.9%, 3% & 7% is a medical device manufactured by Mankind Pharma Limited. It received FDA 510(k) clearance on 2024-04-10 under approval number K232523. The device is classified under product code CAF. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Sodium Chloride Inhalation Solution, USP 0.9%, 3% & 7%?

Sodium Chloride Inhalation Solution, USP 0.9%, 3% & 7% is a medical device that received FDA 510(k) clearance on 2024-04-10. It is manufactured by Mankind Pharma Limited. The 510(k) number is K232523.

When was Sodium Chloride Inhalation Solution, USP 0.9%, 3% & 7% approved by the FDA?

Sodium Chloride Inhalation Solution, USP 0.9%, 3% & 7% received FDA 510(k) clearance on 2024-04-10, under approval number K232523.

What company makes Sodium Chloride Inhalation Solution, USP 0.9%, 3% & 7%?

Sodium Chloride Inhalation Solution, USP 0.9%, 3% & 7% is manufactured by Mankind Pharma Limited.

What is the FDA product code for Sodium Chloride Inhalation Solution, USP 0.9%, 3% & 7%?

The FDA product code for Sodium Chloride Inhalation Solution, USP 0.9%, 3% & 7% is CAF.

Related Clinical Trials

Related Devices (Code: CAF)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.